Skip to content
University of Oxford
You are here:
Our Research
Showing posts for
Vaccine Development
Clear
Development of Oxford COVID-19 vaccine expands into US Phase III clinical trial
2nd Sep 2020
Coronavirus vaccine: steps towards a safe, effective and accessible vaccine
25th Aug 2020
New study reveals Oxford coronavirus vaccine produces strong immune response
20th Jul 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a Phase I/2 randomized control trial
20th Jul 2020
About the Oxford COVID-19 vaccine
19th Jul 2020
Oxford's ChAdOx1 nCoV-19 clinical trials
19th Jul 2020
Trial of Oxford COVID-19 vaccine starts in Brazil
28th Jun 2020
The Duke of Cambridge visits Oxford Vaccine Centre
25th Jun 2020
Trial of Oxford COVID-19 vaccine in South Africa begins
23rd Jun 2020
Oxford University collaborate with Bvlgari to fight COVID-19 and future pandemics
17th Jun 2020
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
14th Jun 2020
Oxford University’s COVID-19 vaccine: next steps towards broad and equitable global access
5th Jun 2020
Oxford COVID-19 vaccine to begin phase II/III human trials
22nd May 2020
Oxford COVID-19 vaccine begins human trial stage
23rd Apr 2020
Covid-19 mortality highly influenced by age demographics
17th Apr 2020
Pagination
Go to page
1
Go to page
2
Go to
Next
page
.jpg?w=50)